An important exception is the striking association between TET2-CH and incident CMML (hazard ratio, 91.5; based on analyses by Kar, Quiros et al., ref. 10), although the absolute risk of developing CMML from TET2-CH is low. This evidence concerns the gene TET2 and chronic myelomonocytic leukemia.